Cargando…
Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation
[Image: see text] The design of new pharmaceutical solids with improved physical and chemical properties can be reached through in-detail knowledge of the noncovalent intermolecular interactions between the molecules in the context of crystal packing. Although crystallization from solutions is well-...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089371/ https://www.ncbi.nlm.nih.gov/pubmed/35557697 http://dx.doi.org/10.1021/acsomega.2c00545 |
_version_ | 1784704503046471680 |
---|---|
author | Araya-Sibaja, Andrea Mariela Fandaruff, Cinira Guevara-Camargo, Ana María Vargas-Huertas, Felipe Zamora, William J. Vega-Baudrit, José Roberto Guillén-Girón, Teodolito Navarro-Hoyos, Mirtha Paoli, Paola Rossi, Patrizia Jones, William |
author_facet | Araya-Sibaja, Andrea Mariela Fandaruff, Cinira Guevara-Camargo, Ana María Vargas-Huertas, Felipe Zamora, William J. Vega-Baudrit, José Roberto Guillén-Girón, Teodolito Navarro-Hoyos, Mirtha Paoli, Paola Rossi, Patrizia Jones, William |
author_sort | Araya-Sibaja, Andrea Mariela |
collection | PubMed |
description | [Image: see text] The design of new pharmaceutical solids with improved physical and chemical properties can be reached through in-detail knowledge of the noncovalent intermolecular interactions between the molecules in the context of crystal packing. Although crystallization from solutions is well-known for obtaining new solids, the effect of some variables on crystallization is not yet thoroughly understood. Among these variables, solvents are noteworthy. In this context, the present study aimed to investigate the effect of ethanol (EtOH), acetonitrile (MeCN), and acetone (ACTN) on obtaining irbesartan (IBS) crystal forms with 2,3-dibromosuccinic acid. Crystal structures were solved by single-crystal diffraction, and the intermolecular interactions were analyzed using the Hirshfeld surfaces analysis. The characterization of physicochemical properties was carried out by powder X-ray diffraction, Fourier transform infrared spectroscopy (FT-IR), thermal analysis, and solution-state NMR techniques. Two different IBS salts were obtained, one from MeCN and ACTN (compound 1) and a different one from EtOH (compound 2). The experimental results were in agreement with the findings obtained through quantum mechanics continuum solvation models. Compound 1 crystallized as a monoclinic system P2(1)/c, whereas compound 2 in a triclinic system P1̅. In both structures, a net of strong hydrogen bonds is present, and their existence was confirmed by the FT-IR results. In addition, the IBS cation acts as a H-bond donor through the N1 and N6 nitrogen atoms which interact with the bromide anion and the water molecule O1W in compound 1. Meanwhile, N1 and N6 nitrogen atoms interact with the oxygen atoms provided by two symmetry-related 2,3-dibromo succinate anions in compound 2. Solution-state NMR data agreed with the protonation of the imidazolone ring in the crystal structure of compound 1. Both salts presented a different thermal behavior not only in melting temperature but also in thermal stability. |
format | Online Article Text |
id | pubmed-9089371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-90893712022-05-11 Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation Araya-Sibaja, Andrea Mariela Fandaruff, Cinira Guevara-Camargo, Ana María Vargas-Huertas, Felipe Zamora, William J. Vega-Baudrit, José Roberto Guillén-Girón, Teodolito Navarro-Hoyos, Mirtha Paoli, Paola Rossi, Patrizia Jones, William ACS Omega [Image: see text] The design of new pharmaceutical solids with improved physical and chemical properties can be reached through in-detail knowledge of the noncovalent intermolecular interactions between the molecules in the context of crystal packing. Although crystallization from solutions is well-known for obtaining new solids, the effect of some variables on crystallization is not yet thoroughly understood. Among these variables, solvents are noteworthy. In this context, the present study aimed to investigate the effect of ethanol (EtOH), acetonitrile (MeCN), and acetone (ACTN) on obtaining irbesartan (IBS) crystal forms with 2,3-dibromosuccinic acid. Crystal structures were solved by single-crystal diffraction, and the intermolecular interactions were analyzed using the Hirshfeld surfaces analysis. The characterization of physicochemical properties was carried out by powder X-ray diffraction, Fourier transform infrared spectroscopy (FT-IR), thermal analysis, and solution-state NMR techniques. Two different IBS salts were obtained, one from MeCN and ACTN (compound 1) and a different one from EtOH (compound 2). The experimental results were in agreement with the findings obtained through quantum mechanics continuum solvation models. Compound 1 crystallized as a monoclinic system P2(1)/c, whereas compound 2 in a triclinic system P1̅. In both structures, a net of strong hydrogen bonds is present, and their existence was confirmed by the FT-IR results. In addition, the IBS cation acts as a H-bond donor through the N1 and N6 nitrogen atoms which interact with the bromide anion and the water molecule O1W in compound 1. Meanwhile, N1 and N6 nitrogen atoms interact with the oxygen atoms provided by two symmetry-related 2,3-dibromo succinate anions in compound 2. Solution-state NMR data agreed with the protonation of the imidazolone ring in the crystal structure of compound 1. Both salts presented a different thermal behavior not only in melting temperature but also in thermal stability. American Chemical Society 2022-04-19 /pmc/articles/PMC9089371/ /pubmed/35557697 http://dx.doi.org/10.1021/acsomega.2c00545 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Araya-Sibaja, Andrea Mariela Fandaruff, Cinira Guevara-Camargo, Ana María Vargas-Huertas, Felipe Zamora, William J. Vega-Baudrit, José Roberto Guillén-Girón, Teodolito Navarro-Hoyos, Mirtha Paoli, Paola Rossi, Patrizia Jones, William Crystal Forms of the Antihypertensive Drug Irbesartan: A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis Investigation |
title | Crystal Forms of the Antihypertensive Drug Irbesartan:
A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis
Investigation |
title_full | Crystal Forms of the Antihypertensive Drug Irbesartan:
A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis
Investigation |
title_fullStr | Crystal Forms of the Antihypertensive Drug Irbesartan:
A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis
Investigation |
title_full_unstemmed | Crystal Forms of the Antihypertensive Drug Irbesartan:
A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis
Investigation |
title_short | Crystal Forms of the Antihypertensive Drug Irbesartan:
A Crystallographic, Spectroscopic, and Hirshfeld Surface Analysis
Investigation |
title_sort | crystal forms of the antihypertensive drug irbesartan:
a crystallographic, spectroscopic, and hirshfeld surface analysis
investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089371/ https://www.ncbi.nlm.nih.gov/pubmed/35557697 http://dx.doi.org/10.1021/acsomega.2c00545 |
work_keys_str_mv | AT arayasibajaandreamariela crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation AT fandaruffcinira crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation AT guevaracamargoanamaria crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation AT vargashuertasfelipe crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation AT zamorawilliamj crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation AT vegabaudritjoseroberto crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation AT guillengironteodolito crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation AT navarrohoyosmirtha crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation AT paolipaola crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation AT rossipatrizia crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation AT joneswilliam crystalformsoftheantihypertensivedrugirbesartanacrystallographicspectroscopicandhirshfeldsurfaceanalysisinvestigation |